ProgramsView all programs
From the news
- Chancellor Amma Addresses the Parliament of World’s Religions
- Amrita Students Qualify for the European Mars Rover Challenge
Publication Type : Journal Article
Publisher : Oxid Med Cell Longev
Source : Oxid Med Cell Longev, Volume 2020, p.5086250 (2020)
Keywords : Alzheimer disease, Animals, Apolipoprotein E4, Genetic Predisposition to Disease, Humans, Molecular Targeted Therapy, Neurofibrillary Tangles, Polymorphism, Genetic, protein folding
Campus : Kochi
School : School of Pharmacy
Department : Pharmaceutical Chemistry & Analysis
Year : 2020
Abstract : Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes chronic cognitive dysfunction. Most of the AD cases are late onset, and the apolipoprotein E () isoform is a key genetic risk factor. The gene has 3 key alleles in humans including , , and . Among them, is the most potent genetic risk factor for late-onset AD (LOAD), while has a defensive effect. Research data suggest that leads to the pathogenesis of AD through various processes such as accelerated beta-amyloid aggregations that raised neurofibrillary tangle formation, cerebrovascular diseases, aggravated neuroinflammation, and synaptic loss. However, the precise mode of actions regarding in what way leads to AD pathology remains unclear. Since contributes to several pathological pathways of AD, targeting might serve as a promising strategy for the development of novel drugs to combat AD. In this review, we focus on the recent studies about -targeted therapeutic strategies that have been advanced in animal models and are being prepared for use in humans for the management of AD.
Cite this Research Publication : A. Al Mamun, Uddin, M. Sahab, Bin Bashar, M. Fahim, Zaman, S., Begum, Y., Bulbul, I. Jahan, Islam, M. Siddiqul, Sarwar, M. Shahid, Bijo Mathew, Amran, M. Shah, Ashraf, G. Md, Bin-Jumah, M. N., Mousa, S. A., and Abdel-Daim, M. M., “Molecular Insight into the Therapeutic Promise of Targeting for Alzheimer's Disease.”, Oxid Med Cell Longev, vol. 2020, p. 5086250, 2020.